tiprankstipranks
NewGenIvf Group (NIVF)
NASDAQ:NIVF
US Market

NewGenIvf Group (NIVF) Financial Statements

25 Followers

NewGenIvf Group Financial Overview

NewGenIvf Group's market cap is currently ―. The company's EPS TTM is $-0.207; its P/E ratio is -4.91; NewGenIvf Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue-$ 0.00-$ 0.00$ 0.00
Gross Profit-----
EBIT-$ -115.64K-$ -122.69K$ -160.03K
EBITDA-$ -115.64K-$ -122.69K$ -160.03K
Net Income Common Stockholders-$ 474.36K-$ -28.54K$ -153.50K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 77.29K$ 54.72K-$ 110.27K$ 726.08K
Total Assets$ 1.45M$ 70.79M-$ 70.10M$ 70.67M
Total Debt$ 353.06K$ 0.00$ 0.00$ 0.00$ 400.00K
Net Debt$ 275.77K$ -54.72K$ 0.00$ -110.27K$ -326.08K
Total Liabilities$ 1.50M$ 2.46M-$ 2.46M$ 3.00M
Stockholders Equity$ 475.74K$ 68.32M-$ 67.64M$ 67.67M
Cash Flow-
Free Cash Flow-$ -32.92K-$ -120.04K$ -351.54K
Operating Cash Flow-$ -32.92K-$ -120.04K$ -351.54K
Investing Cash Flow-$ 0.00-$ 0.00$ -69.69M
Financing Cash Flow-$ 0.00-$ -495.77K$ 70.77M
Currency in USD

NewGenIvf Group Earnings and Revenue History

NewGenIvf Group Debt to Assets

NewGenIvf Group Cash Flow

NewGenIvf Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis